$MYSZ

My Size, Inc. (MYSZ): Results of Operations and Financial Condition

My Size, Inc. (MYSZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale Quarterly revenue reaches $3.1 million; first-half revenue increases 57% to $5.5 million Company enters next phase focused on contribution margin

Original reporting
Published Aug 14, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MYSZ
Bearish
medium confidence
Mentioned
$MYSZ
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MYSZBearishMed
01

Why it matters

The key tradable signals are (1) strong top-line growth, (2) sharp gross margin compression from ~56% to ~31.7% driven by mix, (3) higher operating loss and net loss, and (4) continued but improved operating cash usage in 1H.

02

Market read

Traders will likely reprice the balance between growth and unit economics, given the disclosed mix-driven margin decline and widening losses despite improved operating cash usage.

03

What to watch

Gross margin fell mainly due to revenue mix, so traders should watch whether SaaS and recommerce revenue share rises in subsequent quarters, not just consolidated gross margin.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (Aug 14, 2026) with Q2 and 1H results

Background

This is an SEC 8-K with Exhibit 99.1 reporting MySize’s Q2 and six-month ended June 30, 2026 financial results and management’s updated focus on monetization and cash efficiency.

Company-level read

Ticker impact

$MYSZBearishMedium confidence
Context

MySize reported Q2 2026 revenue of $3.07M (+53% YoY) alongside a wider net loss of about $1.75M and lower gross margin (~31.7%).

Expected impact

Likely downside bias or elevated volatility until management clarifies margin improvement path and cash burn trajectory.

Evidence & confidence

The filing discloses a clear mix shift toward lower-margin commerce, higher sales and marketing expense, and continued operating cash usage ($1.97M used in 1H).

Market effects

Highlights the profitability trade-off for fashion e-commerce scaling versus higher-margin SaaS/recommerce mix.

Limited; company is Israel-based but results are US-listed and not tied to a specific regional macro shock.

Low; no cross-border regulatory or supply-chain shock disclosed.

Counterpoint

Revenue growth and improving operating cash usage (1H cash burn improved to $1.97M) could support a rebound if management’s contribution-margin and operating-leverage plan takes hold.

Key entities

  • MySize, Inc.

    Fashion technology company reporting Q2 2026 results, including revenue growth, margin compression, and cash burn.

  • Percentil

    Resale/recommerce platform; quarterly revenue increased to $413,000 in Q2 2026.

  • Ten Peacks

    International apparel and footwear brand distribution included in the platform; cited as contributing to expense and revenue mix.

Related articles

$MYSZMedAI 8/10

My Size Inc.: MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale

MySize, Inc. (NASDAQ: MYSZ) reported Q2 2026 revenue of $3.07 million, up 53% year over year, and $5.46 million for the first half, up 57%. Percentil revenue rose to $413,000. Gross margin fell to about 31.7% as commerce mix increased. Net loss was $1.75 million. Cash used in operations was $1.97 million for six months.

$TCOMMed

Citi is bullish on these 2 Chinese travel stocks heading into the autumn holidays

Citi reiterated Buy ratings on Tongcheng (THG) and Trip.com (TCOM), citing attractive valuations and upcoming holidays as potential catalysts. Tongcheng reported Q2 2026 revenue of RMB 5.0 billion and net profit of RMB 851 million. Trip.com faces near-term headwinds but is expected to outperform in 2027. Analysts adjusted TCOM's price target to $60, maintaining Buy ratings.

$EMAMed

Emera (EMA) Closes the Book on New Mexico, But Earnings Still Flinch

Emera (EMA) completed the sale of New Mexico Gas Company, marking the end of its asset divestment plan. Q2 2026 earnings showed adjusted EPS at $0.69, down from $0.79 in Q2 2025, due to higher interest expenses and currency losses. The company invested $1.7B in H1 2026 and expects $4B in capital expenditures for the year. Florida operations drove growth, with adjusted profit up to $441M in H1 2026. Management reaffirmed its 5-7% annual adjusted EPS growth target through 2030.

$HBANMed

Huntington Cut Its Outlook Right as the Fed Hiked. First Crack in Regional-Bank Margins?

Huntington Bancshares (HBAN) dropped 5.55% after lowering its 2027 EPS guidance to $1.75-$1.83 and 2026 net interest income growth to ~35%, citing rising deposit costs and loan pricing tightening. The Fed's rate hike exacerbated concerns about regional-bank margins, with peers like Fifth Third also seeing declines. Despite the selloff, Huntington's loan and deposit growth, along with fee income, provide some cushion. Analysts maintain an Overweight rating, with a price target of $21.